Hypoglycemia as a new challenge in traetment with modulatory therapy in patients with cystic fibrosis
Respiratio · 2026 · 16 (1-2) · 60-80
DOI: 10.5937/respira2602060l ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiratio, 2026. Verfasst von Olivera Ljuboja und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
The aim: The discovery of so-called CFTR modulators has set a new milestone in the treatment of cystic fibrosis (CF) for patients with F508del mutations.
Methods
The impact of modulatory therapy on glycoregulation in patients with CF before and one year after the introduction of therapy.
Results
16 patients were treated at the Clinic for Children's Diseases in Banja Luka, clinical, microbiological characteristics, as well as continuous glucose measurement by placing a glucometer were monitored during 12 months of therapy.
Conclusion
The use of a glucose sensor proved to be a superior method compared to OGTT in the treatment of glycoregulation disorders in our patients.
Zitieren
APA
Ljuboja, O., Bukara-Radujković, G., & Tadić, D. (2026). Hypoglycemia as a new challenge in traetment with modulatory therapy in patients with cystic fibrosis. Respiratio, 16(1-2), 60-80. https://doi.org/10.5937/respira2602060l
Vancouver
Ljuboja O, Bukara-Radujković G, Tadić D. Hypoglycemia as a new challenge in traetment with modulatory therapy in patients with cystic fibrosis. Respiratio. 2026;16(1-2):60-80. doi:10.5937/respira2602060l
BibTeX
@article{Ljuboja2026,
author = {Ljuboja, Olivera and Bukara-Radujković, Gordana and Tadić, Daliborka},
title = {Hypoglycemia as a new challenge in traetment with modulatory therapy in patients with cystic fibrosis},
journal = {Respiratio},
year = {2026},
volume = {16},
number = {1-2},
pages = {60--80},
doi = {10.5937/respira2602060l}
}
EUVIMED